Laminin, the major constituent of the lamina rara of basal lamina of epithelia and endothelia, is a trimolecular complex resembling, when assembled, the Coptic Christian cross. Laminin, which in other cell types shows binding affinity for VLA-1, VLA-2, VLA-3, and VLA-6, binds T cells only through VLA-6. Full mapping of the epitope specificity of laminin-VLA-6 interaction on T cells awaits future study. 17 Collagens In SSc, in a study conducted before the full realisation of the potential for costimulatory effects, peripheral blood monocytes from patients with diffuse SSc were shown to initiate DNA synthesis on incubation with laminin. This was taken to represent cell mediated immunity to laminin in SSc without formal proof that the mitogenic signal was transmitted by the T cell receptor (CD3). On reconsideration, if SSc T cells were engaged with another non-laminin epitope by the T cell receptor, the data are consistent with a costimulatory role for laminin in SSc and do not necessarily indicate a direct immune response role. These earlier studies should now be re-examined in light of the potential role ofT cell costimulatory effects.'
Clinically, immune activity relevant to fibrosis can be assessed by serial determinations of serum interleukin 2 concentrations, which have been shown to correlate positively with the progression of skin tautness in a group of 43 patients with diffuse SSc. 9 Endothelial celVvascular studies Morphological evidence for vascular/microvascular involvement in SSc has accumulated for several decades, consisting of arterial intimal proliferation, capillary dilatation and destruction, and ultrastructural evidence for endothelial injury and detachment. The biological era of study began in 1979 with the observation that SSc serum samples (and plasma) contained an endothelial cytotoxic factor, protein in nature, about 50 kDa molecular mass, and associated with a functional decrease in serum serpin or proteinase inhibitor levels in the same serum samples.20 21 In 1990 the endothelial cytotoxic factor was tentatively identified as a serine proteinase present in the granules of activated T lymphocytes called granzyme A in the mouse and granzyme 1 in man.22 Free heightened expression of platelet derived growth factor a (PDGF-a) receptors after eight hours' exposure to transforming growth factor f3 compared with healthy fibroblasts. We propose that the PDGF-a ligand/a receptor system affects wound healing and fibrosis. We are presently engaged in studying the regulation of expression of the a receptor, which is the only receptor through which PDGF-a induces signal transduction, whereas PDGF-,B, the product of the c-sis gene, binds a and f3 receptors equally. Ultimately, we propose that control of SSc fibroblast cell proliferation may be possible through control of PDGF-a ligand/a receptor expression.27
Summing up, unknown stimuli induce a T cell immune response with enhanced lymphocyte adherence to endothelium and release of granzyme 1. These are both likely to contribute to the widespread vascular and microvascular injury that interferes with vascular permeability and exposes the interstitium to one or more fibrogenic cytokines which stimulate fibroblast proliferation and matrix gene expression resulting in fibrosis. Matrix expression continues to activate T cells and the cycle begins anew. Several potential sites at which this cycle can be interrupted represent potential therapeutic strategies for SSc.28
